StockData
IM Cannabis Corp. logo

IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30
$0.49−0.00 (-0.26%)

Close on Nov 17, 2026Market cap $2.91MP/E –Yield –

IM Cannabis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was C$54.73M, up 1.3% from the year before. The highest annual figure on record is C$54.73M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$54.73M+1.3%
FY2024Dec 31, 2024C$54.03M+10.7%
FY2023Dec 31, 2023C$48.80M-10.2%
FY2022Dec 31, 2022C$54.34M+59.6%
FY2021Dec 31, 2021C$34.05M+114.3%
FY2020Dec 31, 2020C$15.89M+75.1%
FY2019Dec 31, 2019C$9.07M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026C$7.59M-40.3%
Q2 FY2025Jun 30, 2025C$12.70M+14.3%
Q2 FY2024Jun 30, 2024C$14.75M–
Q2 FY2023Jun 30, 2023C$13.21M–
Q2 FY2022Jun 30, 2022C$12.70M–
Q2 FY2021Jun 30, 2021C$11.11M–

More IM Cannabis figures

See a number that looks wrong?